CXL Outcomes Consistent Across Populations - Summary - MDSpire
Feature

CXL Outcomes Consistent Across Populations

  • April 16, 2026

  • 3 min

Share

A new international study published in Translational Vision Science & Technology reveals that corneal cross-linking (CXL) is effective for treating keratoconus among diverse ethnic groups and age ranges, despite differences in baseline disease severity. By analyzing 570 eyes from 526 patients in the UK and Saudi Arabia, the researchers found that treatment outcomes were comparable between these populations, with over 80% of eyes stabilizing or improving after three years. The study suggests that demographic factors like ethnicity and age do not significantly impact CXL's efficacy, emphasizing baseline severity as a more critical factor.

Original Source(s)

Related Content